Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|April 24, 2013
Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviewsClaire L Vale, Jayne F Tierney, Sarah Burdett
International Journal of Epidemiology|March 27, 2002
Effects of adjusting for censoring on meta-analyses of time-to-event outcomesClaire L Vale, Jayne F Tierney, Lesley A Stewart
The Cochrane Database of Systematic Reviews|January 22, 2010
Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancerLarysa Rydzewska, Jayne Tierney, Claire L Vale, et al.
The Cochrane Database of Systematic Reviews|December 14, 2012
Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancerLarysa Rydzewska, Jayne Tierney, Claire L Vale, et al.
Systematic Reviews|June 27, 2019
Effectiveness and acceptability of methods of communicating the results of clinical research to lay and professional audiences: protocol for a systematic reviewAnnabelle South, Julia Bailey, Mahesh K B Parmar, et al.
The Cochrane Database of Systematic Reviews|August 17, 2012
Chemotherapy for advanced, recurrent or metastatic endometrial carcinomaClaire L Vale, Jayne Tierney, Sarah J Bull, et al.
British Journal of Cancer|November 29, 2018
Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysisDuncan C Gilbert, Katie Wakeham, Ruth E Langley, et al.
Trials|January 17, 2012
Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: results of a surveyClaire L Vale, Lindsay C Thompson, Claire Murphy, et al.
Implementation Science : IS|February 2, 2024
The effectiveness of interventions to disseminate the results of non-commercial randomised clinical trials to healthcare professionals: a systematic reviewAnnabelle South, Julia V Bailey, Mahesh K B Parmar, et al.
European Urology Focus|February 5, 2019
Evidence Synthesis to Accelerate and Improve the Evaluation of Therapies for Metastatic Hormone-sensitive Prostate CancerJayne F Tierney, Claire L Vale, Wendy R Parelukar, et al.
Pageof 4